Login to Your Account



Celltech's Attempt To Outbid CAT Doesn't Sit Well With OGS Officials

By Nuala Moran


Wednesday, March 5, 2003
LONDON - Oxford GlycoSciences plc offered an instant rebuff to a cash offer of £101.4 million (US$160 million) from Celltech plc, claiming it was a spoiling tactic to undermine the all-paper deal agreed to with Cambridge Antibody Technology Group plc in January. (BioWorld International)

To continue reading subscribe now to BioWorld Asia (formerly International)

Learn More about BioWorld Asia (formerly International)

Already a subscriber? Sign In or Buy now to activate your subscription